We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Expeditors International
EXPD
$23.2B
| $120M | 0.27% |
1,237,915
-74,749
| -6% | -$7.66M |
|
77
NVIDIA
NVDA
$5.42T
| $120M | 0.27% |
7,970,330
-4,681,120
| -37% | -$88.4M |
|
78
Republic Services
RSG
$65.7B
| $119M | 0.27% |
919,202
-498,351
| -35% | -$65.4M |
|
79
Illinois Tool Works
ITW
$84.5B
| $119M | 0.27% |
665,879
-78,901
| -11% | -$15.8M |
|
80
3M
MMM
$94.3B
| $117M | 0.27% |
1,102,628
+163,208
| +17% | +$19.7M |
|
81
Oracle
ORCL
$423B
| $113M | 0.26% |
1,651,133
-411,877
| -20% | -$30.2M |
|
82
Dell
DELL
$293B
| $113M | 0.25% |
2,443,676
+525,681
| +27% | +$24.8M |
|
83
International Paper
IP
$22B
| $113M | 0.25% |
2,693,050
-257,107
| -9% | -$11.9M |
|
84
AutoNation
AN
$6.92B
| $112M | 0.25% |
1,008,532
+66,127
| +7% | +$7.5M |
|
85
Kraft Heinz
KHC
$30B
| $110M | 0.25% |
2,894,171
+1,424,766
| +97% | +$57.1M |
|
86
Huntington Ingalls Industries
HII
$12.8B
| $110M | 0.25% |
509,121
+14,160
| +3% | +$2.99M |
|
87
AutoZone
AZO
$51.1B
| $109M | 0.25% |
51,410
-40,724
| -44% | -$83.8M |
|
88
McKesson
MCK
$101B
| $109M | 0.25% |
333,361
-100,424
| -23% | -$32.1M |
|
89
Labcorp
LH
$25.9B
| $108M | 0.25% |
538,782
+21,238
| +4% | +$4.53M |
|
90
Builders FirstSource
BLDR
$8.04B
| $108M | 0.24% |
2,092,221
+1,049,896
| +101% | +$64.4M |
|
91
Quest Diagnostics
DGX
$26.3B
| $107M | 0.24% |
807,140
+29,422
| +4% | +$4.01M |
|
92
Chubb
CB
$135B
| $106M | 0.24% |
552,010
-241,554
| -30% | -$49.8M |
|
93
Viatris
VTRS
$18.9B
| $106M | 0.24% |
10,095,801
+6,197,249
| +159% | +$67.9M |
|
94
Lockheed Martin
LMT
$136B
| $105M | 0.24% |
243,998
+46,156
| +23% | +$20.3M |
|
95
Lam Research
LRCX
$390B
| $104M | 0.24% |
2,502,610
-633,200
| -20% | -$30.1M |
|
96
Synopsys
SNPS
$79.7B
| $103M | 0.23% |
342,473
-186,905
| -35% | -$56.4M |
|
97
Biogen
BIIB
$30.7B
| $103M | 0.23% |
513,206
+116,900
| +29% | +$23.9M |
|
98
Philip Morris
PM
$295B
| $103M | 0.23% |
1,049,587
-125,461
| -11% | -$12.8M |
|
99
Waste Management
WM
$91B
| $102M | 0.23% |
677,236
-329,718
| -33% | -$51.6M |
|
100
Old Dominion Freight Line
ODFL
$44.9B
| $100M | 0.23% |
802,622
-556,570
| -41% | -$72.9M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.